Skip to content
MS
PW-007 Carbohydrate Metabolism Catabolic unreviewed

Fructose Metabolism (Fructolysis)

Fructose Glyceraldehyde-3-phosphate + DHAP (into glycolysis)
Compartment
Cytosol
Main tissue
Liver (mainly), kidney, small intestine
Rate-limiting
Aldolase B (fructose-1-phosphate aldolase)
Steps
5

Reaction steps

In source order, 5 total

showing 1–5
  1. 1

    Fructose + ATP → fructose-1-phosphate + ADP

    Notes

    Hepatic fructokinase (ketohexokinase) uses ATP and Mg2+ to phosphorylate fructose at carbon 1. This reaction is effectively irreversible and has high capacity but is not tightly feedback-regulated; rapid flux can transiently consume ATP and phosphate when fructose intake is very high.

  2. 2

    Fructose-1-phosphate → dihydroxyacetone phosphate + glyceraldehyde

    Notes

    Aldolase B (fructose-1-phosphate aldolase) cleaves fructose-1-phosphate without a redox cofactor. This is the defining hepatic fructolysis cleavage reaction and is functionally the pathway's critical/committed processing step because failure traps phosphate as fructose-1-phosphate.

  3. 3

    Glyceraldehyde + ATP → glyceraldehyde-3-phosphate + ADP

    Triokinase (glyceraldehyde kinase) ST-0050 Irreversible/directional ATP Mg2+
    Notes

    Triokinase (glyceraldehyde kinase) requires ATP and Mg2+, phosphorylating glyceraldehyde. Glyceraldehyde-3-phosphate and dihydroxyacetone phosphate can then enter glycolysis, gluconeogenesis, glycerol-3-phosphate synthesis, or lipogenesis.

  4. 4

    Dihydroxyacetone phosphate ↔ glyceraldehyde-3-phosphate

    Notes

    Triose phosphate isomerase reversibly interconverts the products of fructolysis as needed for downstream glycolysis or gluconeogenesis. No additional ATP or redox cofactor is used.

  5. 5

    Alternative extrahepatic entry: fructose + ATP → fructose-6-phosphate + ADP

    Hexokinase / Glucokinase 2.7.1.1 / 2.7.1.2 ST-0052 Irreversible/directional ATP Mg2+
    Notes

    Hexokinase can phosphorylate fructose at carbon 6 using ATP and Mg2+, yielding fructose-6-phosphate for entry upstream of PFK-1. This route is generally minor because hexokinase preferentially phosphorylates glucose and because liver fructokinase efficiently clears portal fructose.

Showing all 5 steps.

Regulation

What speeds each enzyme up and what slows it down

Fructokinase (ketohexokinase)

Accelerated by

Substrate availability

Inhibited by

No important physiological allosteric inhibitor

Hormonal

No dominant acute hormonal control; hepatic flux depends largely on fructose delivery

Aldolase B

Accelerated by

Substrate availability

Inhibited by

Product accumulation; loss of activity causes fructose-1-phosphate trapping

Hormonal

No major acute hormonal control

Triokinase

Accelerated by

Substrate availability

Inhibited by

No well-established major physiological allosteric inhibitor

Hormonal

No major acute hormonal control

Overview

Fructose is absorbed from the intestine and is metabolized chiefly in the liver by a pathway that converts it to triose phosphates. Hepatic fructolysis bypasses PFK-1, allowing rapid carbon entry downstream of glycolysis's principal regulatory step. Extrahepatic tissues can phosphorylate fructose through hexokinase, but this route is usually quantitatively minor at physiological fructose concentrations.

Cellular location

The principal fructolysis reactions occur in the cytosol of hepatocytes; kidney cortex and small-intestinal mucosa also express fructokinase and aldolase B. Fructose enters enterocytes mainly through GLUT5 and exits toward portal blood through GLUT2; hepatic uptake is mediated largely by GLUT2. The alternative hexokinase route is cytosolic in muscle, adipose tissue, and other cells.

Net energetics

Conversion of one fructose to two triose phosphates through the liver-specific pathway consumes 2 ATP (one each at fructokinase and triokinase) and produces no NADH, NADPH, FADH2, or GTP in the entry reactions. If both trioses proceed through glycolysis to pyruvate, the downstream payoff is the same as for two glyceraldehyde-3-phosphate molecules: 4 ATP and 2 NADH, giving net 2 ATP and 2 NADH per fructose from fructose to two pyruvate. The bypass of PFK-1 changes regulation, not the overall glycolytic ATP accounting.

Clinical significance

Because hepatic fructolysis supplies trioses below PFK-1, high fructose flux can favor hepatic glycerol-3-phosphate formation, de novo lipogenesis, and triacylglycerol synthesis when energy intake is excessive. Essential fructosuria results from fructokinase deficiency and is typically benign because fructose is excreted or metabolized by alternative pathways. Hereditary fructose intolerance, caused by aldolase B deficiency, produces fructose-1-phosphate accumulation, phosphate/ATP depletion, inhibition of glycogenolysis and gluconeogenesis, severe hypoglycemia, vomiting, jaundice, and potential liver failure after fructose, sucrose, or sorbitol ingestion.

Recent literature

Live Europe PMC search

Europe PMC · fetched just now · sorted by publication date

  1. 1
    Transposon insertion sequencing identifies novel genes involved in product synthesis in gas-fermenting <i>Clostridium ljungdahlii</i>.

    Zhang Z, Yang F, Liu Y, Ye W, Jia D, Tian Y, Jiang W, Wang Q, Gu Y. · 2026-05-09

    open access unreviewed
  2. 2
    Overconsumption of fructose aggravates acute GVHD by inducing gut dysbiosis and promoting macrophage-mediated inflammatory response.

    Wu K, Yu H, Cao K, Dai B, Yuan Y, Qian X, Zhong H, Qu Y, Jiang H, Chen T. · 2026-03-13

    open access unreviewed
  3. 3
    Preclinical advances and mechanistic insights of CAR-T therapy for acute myeloid leukemia: from target iteration to microenvironment regulation.

    Xiao Y, Liu L, Liu S, Wang L, Tian J, Shao Z, Shi J, Cui C. · 2026-03-09

    open access unreviewed
  4. 4
  5. 5
    Metabolism of fructose in the heart favors glycerate production and is linked to cardiac dysfunction in diabetes.

    Annandale M, Lachance D, Robillard IF, Guo G, Li X, Koutsifeli P, Daniels LJ, Zarate E, Grey AC, Delbridge LM… · 2026-08-08

    unreviewed
  6. 6
    Microbiota-Neuroinflammation Crosstalk in Primary Brain Tumors: Focus on Glioblastoma.

    AlRamadneh TN, S RJ, Nayak PP, Nanda A, Hasnaawei SA, Bhatt A, Chauhan AS, Singla S, Nourizadeh M. · 2026-08-01

    unreviewed
  7. 7
  8. 8
  9. 9
    On the Origin of the Brain Semi-Heavy Water Deuterium MR Signal Following Administration of Deuterated Metabolic Substrate: A Cautionary Tale.

    Ackerman JJH, Ge X, Rensing N, Neil JJ, Thio LL, Garbow JR. · 2026-03-24

    open access unreviewed
  10. 10
    Endogenous fructose production in patients and mice with aldolase B deficiency.

    Buziau AM, Simons N, Tolan DR, Caiment F, Scheijen JLJM, van de Waarenburg MP, Schalkwijk CG, Brouwers MCGJ. · 2026-07-17

    unreviewed

External claims. These come from an index outside this database and are not checked against it. Treat them as leads.